Back to top

BioXcel Therapeutics Announces Publication in Frontiers in Pharmacology on the Effects of ...

BioXcel Therapeutics Announces Publication in Frontiers in Pharmacology on the Effects of Dexmedetomidine (the active ingredient in BXCL-501) on Stress-Mediated Behaviors in Non-clinical Studies | BTA

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioXcel Therapeutics, Inc. (BTAI)